Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer
1 other identifier
interventional
27
1 country
1
Brief Summary
Radiation therapy (RT) is often used to treat breast cancer. RT combined with breast surgery is associated with better outcomes in early stage breast cancer compared to surgery alone. Fatigue is one of the most important side effects of RT because it can decrease patients' quality of life. Studies found that physical activity (PA) may help to improve quality of life in cancer survivors. PA has been reported to lower fatigue, anxiety, and depression. Physical inactivity over a long period of time may lead to rapid energy and physical function loss. PA intervention studies in patients undergoing RT have included mostly White patients. There is no evidence on African American patients undergoing RT. The purpose of this study is to examine the efficacy of a structured, moderate-intensity, aerobic exercise program in reducing cancer-related fatigue in African Americans undergoing RT for localized breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jun 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 26, 2014
CompletedFirst Posted
Study publicly available on registry
April 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 27, 2020
January 1, 2020
11 months
March 26, 2014
January 22, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Reduce cancer-related fatigue
Fatigue Cancer-related fatigue will be determined using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) survey instrument. The FACIT-Fatigue is a 13-item subscale developed to identify a finite set of concerns specific to fatigue. The responses to the 13 items on the FACIT fatigue questionnaire are each measured on a 4-point Likert scale. Thus, the total score ranges from 0 to 52. The FACIT-Fatigue scale has been validated in patients with cancer and showed excellent internal consistency and reliability.
8 weeks
Secondary Outcomes (1)
Increase quality of life
8 weeks
Study Arms (2)
Physical activity
OTHERAn 8-week structured, moderate-intensity aerobic training exercise regimen concurrent with their radiation therapy (N=15),
Control
NO INTERVENTIONPatients will continue with usual care, which includes radiation treatment.
Interventions
Those participants randomized to the exercise group will be required to exercise 5 days/week for 8 weeks coinciding with the radiation treatment sessions. The exercise intervention will consist of aerobic training. Participants will be required to meet and maintain a goal of 75 min/week of aerobic exercise by using portable cycle ergometers; that is; 15 min/day for 5 days/week. The cycle ergometer consists of two cycling pedals mounted to a stationary block that allows patients to exercise while sitting. The tension on the pedals can be adjusted to provide desired tension. Patients can also move the equipment so they can use it conveniently while sitting anywhere and with any chair.
Eligibility Criteria
You may qualify if:
- over 18 years old or less than 75 years old.
- histologically confirmed carcinoma of the breast
- radiation therapy naive
- sedentary, as defined as \<60 minutes of recreation or work requiring modest PA/week based on the 7 day physical activity recall questionnaire
- ambulatory
- negative serum pregnancy test and not planning to be pregnant in the next 3 months
- ability to understand and the willingness to sign a written informed consent.
- have breast cancer stage 0-IIIA
- completed neo-adjuvant or adjuvant chemotherapy may be concurrently receiving endocrine or HER2 directed therapy
You may not qualify if:
- age less than 18 years old or more than 75 years
- no histological confirmation of breast cancer
- prior breast, chest or pelvic radiotherapy
- concurrent chemotherapy
- distant metastases
- physical limitations (e.g., orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking program
- a positive pregnancy test, currently pregnant or planning to become pregnant in the next three months
- identified as the active or maintenance stage of exercise behavior
- psychiatric disorder which would render the subject unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia, 20057, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucile Adams-Campbell
Georgetown University
- STUDY DIRECTOR
Pamela Randolph-Jackson
Medstar Health Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2014
First Posted
April 17, 2014
Study Start
June 1, 2013
Primary Completion
May 1, 2014
Study Completion
December 1, 2015
Last Updated
January 27, 2020
Record last verified: 2020-01